IG News

Keeping you informed of the latest developments in the IG industry and community, the following are a few articles which may be of interest to you as patients. Please click the link to be redirected to the full article and news source:

Coronavirus COVID-19 News

COVID-19 Patient/Household Member/Nurse Screen
As of 01/18/2020

COVID-19 Vaccination Information
As of 03/05/2021

Thank You for Your Bravery and Courage

Rest Assured Nufactor is Available for You
As of 03/19/2020

Coronavirus: What to Know & What to Do
As of 03/05/2020

Nufactor® Receives URAC's 2022 Pioneer Award in Performance Measurement for Second Consecutive Year

CND Life Sciences Partners With FFF Enterprises And NuFactor - Strategic Collaboration Educates Neurology Community About Syn-One Test™

Nufactor Receives URAC's Leaders in Performance Measurement 2021 Pioneer Award

FFF Enterprises and its subsidiaries, Nufactor, MinibarRx and InCircle achieve HITRUST CSF® Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

Nufactor Achieves Immune Globulin National Society's (IgNS) Ig Certified Pharmacist (IgCP®) Credentials for 18 Pharmacists Eligible to Take the Exam

Nufactor's California Pharmacy Recognized as First Pharmacy to Achieve Immunoglobulin National Society's (IgNS) Ig Certified Pharmacist (IgCP®) Credentialing

Nufactor® Selected by Grifols to be Included in the Limited Network of Specialty Pharmacies for XEMBIFY®
December, 2019

Immune Globulin (IG) Shortage 2019
August, 2019

A National Increase in the Demand of Immune Globulin
July, 2019

Nufactor Selected as One of the Limited Distribution (LD) Pharmacies for Cutaquig®
June, 2019

Shire Announces U.S. FDA Approval of CUVITRU[TM] [Immune Globulin Subcutaneous (Human), 20% Solution] Treatment for Primary Immunodeficiency
September, 2016

CSL Plasma Raises Over $118,000 for the Immune Deficiency Foundation
July, 2016

Bio Products Laboratory, Ltd Announces FDA Submission of Biologics License Supplement for Gammaplex 10%
July, 2016

Kedrion 10% Safe and Effective for Treating PI
January, 2016

GSP, Italian partners file 'bubble boy' gene therapy in EU
May, 2015

The information provided on this website is not medical advice, nor is it intended to be a substitute for medical advice, diagnosis, and treatment. Always seek the advice of a physician or other qualified health provider with questions concerning a medical condition. Never disregard professional medical advice, or delay seeking it based on information provided on this website.